35523-93-4 Usage
Uses
Used in Pharmaceutical Industry:
2H-Indol-2-one, 1,3-dihydro-4-phenylis used as an intermediate in the synthesis of pharmaceuticals for its potential biological and pharmacological activities. It serves as a building block in the development of novel drugs, contributing to the advancement of medicinal chemistry.
Used in Organic Compounds Synthesis:
In the field of organic chemistry, 2H-Indol-2-one, 1,3-dihydro-4-phenylis utilized as a key intermediate in the preparation of various organic compounds. Its unique structure allows for the creation of a wide range of chemical entities with diverse applications.
Used in Research and Development:
2H-Indol-2-one, 1,3-dihydro-4-phenylis employed in research settings to explore its potential as an antipsychotic and antihypertensive agent. Scientists investigate its properties and interactions to better understand its therapeutic potential and to develop new treatments for various conditions.
Used in Drug Discovery:
As a compound with demonstrated biological activity, 2H-Indol-2-one, 1,3-dihydro-4-phenylis used in drug discovery processes. It is studied for its potential to treat specific diseases and disorders, with the aim of identifying new therapeutic agents that can be brought to market for patient use.
Check Digit Verification of cas no
The CAS Registry Mumber 35523-93-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,5,2 and 3 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 35523-93:
(7*3)+(6*5)+(5*5)+(4*2)+(3*3)+(2*9)+(1*3)=114
114 % 10 = 4
So 35523-93-4 is a valid CAS Registry Number.
35523-93-4Relevant academic research and scientific papers
Indolinone derivatives as protein kinase/phosphatase inhibitors
-
, (2008/06/13)
The present invention relates to certain 2-indolinone compounds which modulate the activity of protein kinases (“PKs”) and phosphatases. The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones
-
, (2008/06/13)
This invention relates to novel compounds having the formula: STR1 wherein; R1 is fluoro, chloro, bromo, lower-alkyl or nitro, R2 is lower alkyl, lower alkoxy, fluoro, chloro, bromo, nitro or trifluoromethyl, and m and n are 0-2 with the proviso that when R1 or R2 are tertiary butyl or a sterically hindering lower alkyl radical, m and/or n are 1. These compounds are intermediates in the preparation of 2-aminobiphenylacetic acids, esters and metal salts thereof.
2-Amino-6-biphenylacetic acids
-
, (2008/06/13)
Novel 2-amino-6-biphenylacetic acids, esters, and metal salts are provided of the formula: STR1 wherein R represents hydrogen or lower alkyl, R1 represents fluoro, chloro, bromo, lower-alkyl or amino; R2 represents lower-alkyl, lower
